Page 54 - Read Online

Page 10 of 14 Lu et al. Microbiome Res Rep 2024;3:17 https://dx.doi.org/10.20517/mrr.2023.44

Figured the picture: Zhang H

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by the National Natural Science Foundation of China (Nos. 32170058 and
81874038), National Key Research and Development Program of China (No. 2018YFC2000500).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2024.

REFERENCES
1. Zuo L, Iv Y, Wang Q, et al. Early-recurrent overt hepatic encephalopathy is associated with reduced survival in cirrhotic patients
after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2019;30:148-53.e2. DOI
2. Clayton M. Hepatic encephalopathy: causes and health-related burden. Br J Nurs 2018;27:S4-6. DOI PubMed
3. Fischer JE, Funovics FJ, Falcao HA, Wesdorp RI. L-dopa in hepatic coma. Ann Surg 1976;183:386-91. DOI PubMed PMC
4. Xu XY, Ding HG, Li WG, et al. Chinese guidelines on management of hepatic encephalopathy in cirrhosis. World J Gastroenterol
2019;25:5403-22. DOI PubMed PMC
5. Pabst O, Hornef MW, Schaap FG, Cerovic V, Clavel T, Bruns T. Gut-liver axis: barriers and functional circuits. Nat Rev
Gastroenterol Hepatol 2023;20:447-61. DOI PubMed
6. Kilgore A, Belkind-Gerson J. The bidirectional brain-gut-microbiome axis in pediatrics: what we know and what lies ahead. J Pediatr
Gastroenterol Nutr 2023;77:147-9. DOI
7. Smith ML, Wade JB, Wolstenholme J, Bajaj JS. Gut microbiome-brain-cirrhosis axis. Hepatology 2023;Online ahead of print. DOI
PubMed PMC
8. Wang PYT, Caspi L, Lam CKL, et al. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature
2008;452:1012-6. DOI PubMed
9. Stadlbauer V, Wright GAK, Jalan R. Role of artificial liver support in hepatic encephalopathy. Metab Brain Dis 2009;24:15-26. DOI
PubMed
10. Pennisi E. Human genome 10th anniversary. Digging deep into the microbiome. Science 2011;331:1008-9. DOI PubMed
11. Li F, Wang Q, Han Y, et al. Dietary pterostilbene inhibited colonic inflammation in dextran-sodium-sulfate-treated mice: a
perspective of gut microbiota. Infect Microbes Dis 2021;3:22-9. DOI
12. Zeevi D, Korem T, Godneva A, et al. Structural variation in the gut microbiome associates with host health. Nature 2019;568:43-8.
DOI
13. Yang Y, Bin P, Tao S, et al. Evaluation of the mechanisms underlying amino acid and microbiota interactions in intestinal infections
using germ-free animals. Infect Microbes Dis 2021;3:79-86. DOI
14. Moore MD, Suther C, Zhou Y. Microbiota, Viral infection, and the relationship to human diseases: an area of increasing interest in
the SARS-CoV-2 pandemic. Infect Microbes Dis 2021;3:1-3. DOI PMC
15. Segre JA. MICROBIOME. Microbial growth dynamics and human disease. Science 2015;349:1058-9. DOI PubMed
16. Morais LH, Schreiber HL 4th, Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol
2021;19:241-55. DOI PubMed
17. Martin CR, Osadchiy V, Kalani A, Mayer EA. The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol 2018;6:133-48. DOI
PubMed PMC
18. Laue HE, Coker MO, Madan JC. The developing microbiome from birth to 3 years: the gut-brain axis and neurodevelopmental
outcomes. Front Pediatr 2022;10:815885. DOI PubMed PMC
19. Niemarkt HJ, De Meij TG, van Ganzewinkel CJ, et al. Necrotizing enterocolitis, gut microbiota, and brain development: role of the